Tap on and choose 'Add to Home Screen' to create a shortcut app

Tap on and choose 'Add to Home Screen/Install App' to create a shortcut app

Outcome of Therapies for Neurocysticercosis in Children

This page was last updated on September 23rd, 2020

  • Several factors effect outcome: Type of NCC, cyst location (parenchymal better than extraparenchymal), and number of lesions (solitary ring-enhancing lesion better than multiple). Outcomes seem to be better with endoscopic removal than with open procedures (30)(44).
  • Solitary ring-enhancing lesion has a good prognosis: More than 60% of solitary, ring-enhancing lesions will disappear within 6 months. Good control of seizures is expected (44).
  • Poorer prognosis in children with encephalitis and the racemose forms of NCC: Cysts that lodge or develop within the subarachnoid spaces of the brain, including cisterna magna and sylvian fissure, usually have considerable morbidity (30,44).
  • Seizure outcome: Nearly 80–85% of patients with SHL have a good seizure outcome after resolution of the lesion and early withdrawal of anti-epileptic drugs. A higher risk of recurrence is observed when follow-up CAT scans show calcified residual granuloma (44,45)

Your donations keep us going

The ISPN Guide is free to use, but we rely on donations to fund our ongoing work and to maintain more than a thousand pages of information created to disseminate the most up-to-date knowledge in the field of paediatric neurosurgery.

By making a donation to The ISPN Guide you are also indirectly helping the many thousands of children around the world whose treatment depends on well-informed surgeons.

Please consider making a donation today.

Use the app

The ISPN Guide can be used as a standalone app, both on mobile devices and desktop computers. It’s quick and easy to use.

Fully featured

Free registration grants you full access to The Guide and host of featured designed to help further your own education.

Stay updated

The ISPN Guide continues to expand both in breadth and depth. Join our mailing list to stay up-to-date with our progress.